 BOSTON, March 21, 2022 GLOBE NEWSWIRE -- Praxis Precision Medicines, Inc. NASDAQ: PRAX, a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system CNS disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will participate in a fireside chat at Stifels 4th Annual CNS Day on Tuesday, March 29, 2022 at 11:30 a.m. ET. 